View Post Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide–Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study. Journal of Acquired Immune Deficiency Syndromes, 87(2): 794-800. In by AHFJune 15, 2021
View Post Ending AIDS As a Public Health Threat by 2030: Time to Reset Targets for 2025. PLOS Medicine, 18(6): 1-5. In by AHFJune 15, 2021
View Post Acute Human Immunodeficiency Testing and Linkage to Care: An Evaluation of Community-based 4th Generation Antigen/Antibody Testing. Journal of AIDS and HIV Research, 13(1): 16-21. In by AHFJune 1, 2021
View Post A Global Public Health Convention for the 21st Century. The Lancet, 6: e428-e433. In by AHFMay 15, 2021
View Post High Post-Exposure Prophylaxis Uptake but Low Completion Rates and HIV Testing Follow-Up in Health Workers, Harare, Zimbabwe. The Journal of Infection in Developing Countries, 15(4): 559-565. In by AHFApril 15, 2021
View Post Weight Gain Before and After Switch from TDF to TAF in a U.S. Cohort Study. Journal of the International AIDS Society, 24(4): 1-9. In by AHFApril 15, 2021
View Post Weight Gain Before and After Switch from TDF to TAF in a U.S. Cohort Study. Journal of the International AIDS Society, 24(4): 1-9. In by AHFApril 1, 2021
View Post Decentralised HIV Care During the COVID-19 Pandemic: Ensuring Safe Community-Based Services. South African Medical Journal, 111(8): 698. In by AHFMarch 15, 2021
View Post Clinical Factors Associated with Accurate Presumptive Treatment of Neisseria gonorrhoeae Infections in Men Who Have Sex with Men and Transgender Women. Clinical Infectious Diseases, 1-7. In by AHFFebruary 1, 2021
View Post Depression and Anxiety as Barriers to Art Initiation, Retention in Care, and Treatment Outcomes in KwaZulu-Natal, South Africa. eClinicalMedicine, 31: 1-7. In by AHFJanuary 15, 2021
